Lansoprazolo Teva Italia (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This irreversible inhibition stops the final step of gastric acid secretion, leading to a sustained increase in stomach pH.

The appropriate dose of Lansoprazolo Teva Italia is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the prescribing clinician after evaluating the individual situation.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the proton pump inhibitor (PPI) class, similar to omeprazole, esomeprazole and pantoprazole. All PPIs share the same mechanism of acid suppression, but differences in pharmacokinetics, drug‑interaction profiles and individual patient response may influence the choice of agent.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect it from moisture and light, and keep it out of reach of children.

Lansoprazolo Teva Italia is taken orally, usually as a whole tablet with water. It is commonly administered before a meal, but patients should follow the specific timing instructions provided by their prescriber.

Serious adverse events, although rare, include Clostridioides difficile‑associated diarrhea, acute interstitial nephritis, and severe hypersensitivity reactions such as rash, angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience these symptoms.

Individuals with a known hypersensitivity to lansoprazole or any other proton pump inhibitor should avoid this medication. Caution is also advised for patients with severe liver impairment, those on interacting drugs such as clopidogrel, and patients who have experienced previous severe adverse reactions to PPIs.